Investigation Overview
An investigation on behalf of current long-term investors in shares of Windtree Therapeutics, Inc. (OTC: WINT) was announced over potential breaches of fiduciary duties by certain officers and directors at Windtree Therapeutics. The investigation by a law firm concerns whether certain Windtree Therapeutics directors breached their fiduciary duties and caused damage to the company and...
You must register (for free) or login to view the entire investigation.